Want to join the conversation?
$SRCL 2Q15 Q&A: David of Robert W. Bair: Change in revenue outlook? I assume that's pretty standard acquisitions being offset by worsening affection. Can you put any numbers around the FX piece? Dan, CFO: Our previous guidance was about 2.81 to 2.86. We beat the Street estimates by about $7MM, so we raised that by about $7MM there.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?